When.com Web Search

  1. Ads

    related to: glp-1 hormone

Search results

  1. Results From The WOW.Com Content Network
  2. Glucagon-like peptide-1 - Wikipedia

    en.wikipedia.org/wiki/Glucagon-like_peptide-1

    Glucagon-like peptide-1 (GLP-1) is a 30- or 31-amino-acid-long peptide hormone deriving from the tissue-specific posttranslational processing of the proglucagon peptide. It is produced and secreted by intestinal enteroendocrine L-cells and certain neurons within the nucleus of the solitary tract in the brainstem upon food consumption.

  3. What Are GLP-1 Medications & Who Should Use Them? Here ... - AOL

    www.aol.com/glp-1-medications-them-heres...

    GLP-1 agonists are a class of medications that mimic the action of the hormone GLP-1 (glucagon-like peptide-1), which is involved in insulin production and appetite regulation. “GLP-1 stands for ...

  4. Comparing Oral vs. Injectable Semaglutide: Is One More ... - AOL

    www.aol.com/comparing-oral-vs-injectable...

    Semaglutide is a glucagon-like peptide-1 receptor agonist. It works by mimicking GLP-1 hormone, which is naturally produced in your intestines. ... Blocking the body from making glucagon, a ...

  5. 6 Common Side Effects from Taking a GLP-1 Medication ... - AOL

    www.aol.com/6-common-side-effects-taking...

    GLP-1 (short for glucagon-like peptide-1) medications are meant to help manage blood sugar levels and appetite, and they have changed the landscape of diabetes management and weight loss in recent ...

  6. Glucagon-like peptide-1 receptor - Wikipedia

    en.wikipedia.org/wiki/Glucagon-like_peptide-1...

    The GLP-1R is a G protein-coupled receptor that is dependent on glucose and GLP-1 is a peptide hormone that acts directly on the beta cell to stimulate insulin secretion by activating signal transduction when glucose is present.

  7. GLP1 poly-agonist peptides - Wikipedia

    en.wikipedia.org/wiki/GLP1_poly-agonist_peptides

    GLP1 poly-agonist peptides [1] are a class of drugs that activate multiple peptide hormone receptors including the glucagon-like peptide-1 (GLP-1) receptor.These drugs are developed for the same indications as GLP-1 receptor agonists—especially obesity, type 2 diabetes, and non-alcoholic fatty liver disease.